Edmonton-made vaccine prepares for next phase of clinical trials
A COVID-19 vaccine developed in Edmonton is moving to the next stage of clinical trials.
The CEO of Entos Pharmaceuticals says the results of the phase one trials were exactly what they were hoping to see. Now the company is preparing for phase two.
"It was completely safe, completely well tolerated and produced the kind of response we wanted," said CEO John Lewis.
Since there are already approved COVID-19 vaccines for Canadians, Lewis says the company decided it wasn't feasible to conduct a primary immunization trial in Canada. The next stage of trials will take place in Honduras, South Africa and possibly India.
"We're running the clinical in areas where we know we can run a high quality clinical trial where approved vaccines are just not available," said Lewis.
"A clinical trial is a great option for an individual, and also because this is the kind of vaccine that would be very suitable for distribution in low and middle income countries."
The vaccine is made using DNA instead of RNA making it easier to transport and store at lower temperatures.
Lewis says the DNA vaccine is stable in a regular fridge for over a year, and stable at room temperature for over a month.
"We see this as a key tool on our quest to get the world vaccinated," said Lewis.
CTVNews.ca Top Stories
A newspaper says video of Prince William and Kate should halt royal rumour mill. That's a tall order
Prince William and his wife Catherine have been filmed at a farm shop near their Windsor home, The Sun newspaper reported -- the first footage of Kate since she had abdominal surgery for an unspecified condition two months ago.
'You ask for your money, they disappear': Ontario man loses $17K to AI crypto scam
A Toronto man is spreading the word of a cryptocurrency scam that lures victims using AI-generated news sites after he lost $17,000 in investments.
Hertz CEO out following electric car 'horror show'
The company, which announced in January it was selling 20,000 of the electric vehicles in its fleet, or about a third of the EVs it owned, is now replacing the CEO who helped build up that fleet, giving it the company’s fifth boss in just four years.
High thoughts: The habits of Canadian cannabis users are revealed in a new StatCan report
Statistics Canada has conducted a series of surveys to measure the impacts of legalized cannabis since the Cannabis Act took effect in 2018. The latest one, the 2023 National Cannabis Survey, sheds light on users' preferences and habits last year.
Demand soars for solar eclipse glasses in Canada. Are they worth buying?
The demand for total solar eclipse glasses used to safely view the rare celestial event has been ramping up as sellers, along with astronomy and eye-care experts in Canada, warn that viewing the eclipse with the naked eye is dangerous.
Trump says Jews who vote for Democrats 'hate Israel' and their religion
Former U.S. president Donald Trump on Monday charged that Jews who vote for Democrats 'hate Israel' and hate 'their religion,' igniting a firestorm of criticism from the White House and Jewish leaders.
Toronto family doctor who called patient's body 'perfect' suspended for 3 months: tribunal
A family doctor in Toronto has been suspended for three months after a disciplinary tribunal found that he failed to follow proper protocols while examining a patient's breasts and made inappropriate comments about her body.
Freddie Mercury's home is on the market for first time since 1980 minus his 'exquisite clutter'
Freddie Mercury's sanctuary in London, where he lived the last decade of his life, is on sale for the first time in nearly half a century -- minus his "exquisite clutter."
'The lost season': Winter comes to a close as Canada's warmest on record
The warmest winter on record could have far-reaching effects on everything from wildfire season to erosion, climatologists say, while offering a preview of what the season could resemble in the not-so-distant future unless steps are taken to cut greenhouse gas emissions.